Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

FDA clears Bayer's cholesterol-lowering agent

July 10, 1997

Exocell presents humanized MAb for diabetic nephropathy

July 10, 1997

Novel hemoregulatory compounds from SKB

July 10, 1997

Update on Pfizer/Ligand treatments for osteoporosis and breast cancer

July 9, 1997

MGI Pharma launches INFeD for anemia in cancer patients

July 9, 1997

Oxford GlycoSciences licenses compound for treatment of glycolipid storage disorders

July 9, 1997

Didronel PMO now available for expanded use in the U.K.

July 9, 1997

Lilly reports new salt of PKC inhibitor with improved pharmaceutical properties

July 9, 1997

SmithKline Beecham focuses on hemoregulatory compounds

July 9, 1997

Senetek seeks Danish approval of erectile dysfunction therapy

July 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...